Christopher Mutz
Head Of Rare Disease at Ani Pharmaceuticals Inc (ANIP)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.6M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Mar 13SEC | ANIPAni Pharmaceuticals Inc | Sell Plan | 3,16291,309 held (−3%) | $71.64 | $227K | +3.1% |
| Mar 10SEC | ANIPAni Pharmaceuticals Inc | Sell Plan | 2,121101,387 held (−2%) | $74.22 | $157K | -0.4% |
| Mar 10SEC | ANIPAni Pharmaceuticals Inc | Sell Plan | 3,60294,471 held (−4%) | $74.18 | $267K | -0.4% |
| Mar 4SEC | ANIPAni Pharmaceuticals Inc | Sell Plan | 417103,508 held (−0%) | $74.00 | $31K | -0.1% |
| Feb 23SEC | ANIPAni Pharmaceuticals Inc | Sell Plan | 5,32384,840 held (−6%) | $78.02 | $415K | -5.3% |
| Feb 17SEC | ANIPAni Pharmaceuticals Inc | Sell Plan | 7,03292,566 held (−7%) | $76.55 | $538K | -3.5% |
- Sell
Head Of Rare Disease Christopher Mutz sold $227K of ANIP at $71.64 — pre-scheduled 10b5-1 plan sale.
- Sell
Head Of Rare Disease Christopher Mutz sold $157K of ANIP at $74.22 — pre-scheduled 10b5-1 plan sale.
- Sell
Head Of Rare Disease Christopher Mutz sold $267K of ANIP at $74.18 — pre-scheduled 10b5-1 plan sale.
- Sell
Head Of Rare Disease Christopher Mutz sold $31K of ANIP at $74.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Head Of Rare Disease Christopher Mutz sold $415K of ANIP at $78.02 — pre-scheduled 10b5-1 plan sale.
- Sell
Head Of Rare Disease Christopher Mutz sold $538K of ANIP at $76.55 — pre-scheduled 10b5-1 plan sale.